Tan, Shiow Chin Spearheading Covid-19 research: this new institute was the only research facility allowed to operate fully when the University of Cambridge shut down due to the Covid-19 pandemic. In Sunday Star. StarHealth, (11 September 2022), p. 6.
![[img]](http://libraryarchive.sunway.edu.my/style/images/fileicons/text.png) |
Text
2022_09_11. Star. Spearheading covid-19 research.pdf - Published Version Restricted to Repository staff only (2MB) | Request a copy |
| Item Type: | News Clippings |
|---|---|
| Additional Information: | P1: The CITIID Initially focused on research that could help the immediate response to the pandemic in an effort to help alleviate the burden on the UK National Health Service (NHS). P2: Prof Smith shares that as the only Cambridge institute allowed to remain fully open during the UK lockdown, the CITIID soon became the hub of research and volunteer activity on the university's Biomedical Campus. P3: Among the facilities contained in the Jeffrey Cheah Biomedical Centre is the largest biosafety level 3 lab run by academics in the UK. |
| Keywords: | Cambridge Institute of Therapeutic Immunology and Infectious Disease; CITIID; Jeffrey Cheah Biomedical Centre; SARS-CoV-2; World Health Organization; WHO; Ken Smith; Covid-19; Stephen Baker; Ian Goodfellow; Covid-19 Genomics UK Consortium; COG-UK; Sharon Peacock; Ewan Harrison; Wellcome-MRC Cambridge Stem Cell Institute; the Milner Therapeutics Institute; Cambridge Centre for Myelin Repair; biosafety level 3 lab; |
| Subjects: | H > health issues |
| Divisions: | Jeffrey Cheah Biomedical Centre, Cambridge University Biomedical Campus |
| Depositing User: | Ms Juwairiah Tan Sulaiman |
| Date Deposited: | 01 Apr 2024 06:00 |
| Last Modified: | 01 Apr 2024 06:00 |
| URI: | http://libraryarchive.sunway.edu.my/id/eprint/5022 |
Actions (login required)
 |
View Item |
